Real‐life Use of Anticoagulants in Venous Thromboembolism With a Focus on Patients With Exclusion Criteria for Direct Oral Anticoagulants-Reference-Cited by-同舟云学术

Real‐life Use of Anticoagulants in Venous Thromboembolism With a Focus on Patients With Exclusion Criteria for Direct Oral Anticoagulants

Published:2017-08-07 Issue:4 Volume:103 Page:684-691
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Moustafa Farès¹,Pesavento Raffaele²,di Micco Pierpaolo³,González‐Martínez José⁴,Quintavalla Roberto⁵,Peris Maria‐Luisa⁶,Porras José Antonio⁷,Falvo Nicolas⁸,Baños Pilar⁹,Monreal Manuel¹⁰,

Affiliation:

1. Department of EmergencyCHU Clermont‐Ferrand, Université Clermont AuvergneClermont‐Ferrand France

2. Department of Medicine‐DIMED2^nd Chair of Internal Medicine, University of PaduaPadua Italy

3. Department of Internal Medicine and Emergency RoomOspedale Buon Consiglio FatebenefratelliNaples Italy

4. Department of Internal MedicineALTAHAIA, Xarxa Assistencial de ManresaBarcelona Spain

5. Department of Medicine 3Azienda Ospedaliera UniversitariaParma Italy

6. Department of Internal MedicineConsorcio Hospitalario Provincial de Castellón, Ceu Cardenal Herrera UniversityCastellón Spain

7. Department of Internal MedicineHospital Universitario Joan XXIII de TarragonaTarragona Spain

8. Department of Internal MedicineCHU de Dijon, Hôpital du BocageDijon France

9. Department of Internal MedicineHospital de Can MissesIbiza Spain

10. Department of Internal MedicineHospital Universitario Germans Trias i Pujol de Badalona, Barcelona, Universidad Católica de Murcia Spain

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.781

Reference34 articles.

1. Antithrombotic Therapy for VTE Disease

2. Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

3. Oral Apixaban for the Treatment of Acute Venous Thromboembolism

4. Oral Rivaroxaban for Symptomatic Venous Thromboembolism

5. Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer-associated thrombosis: How many patients seen in clinical practice would be eligible for a direct oral anticoagulant randomized controlled trial?;Respiratory Medicine and Research;2024-06

2. Efficacy and Safety of Different Anticoagulation Regimens for Deep Vein Thrombosis in Real Clinical Practice;Journal of Venous Disorders;2024

3. Reducing bleeding risk in patients on oral anticoagulation therapy;Expert Review of Cardiovascular Therapy;2023-11-08

4. Bleeding Risk in Elderly Patients with Venous Thromboembolism Who Would Have Been Excluded from Anticoagulation Trials;Thrombosis and Haemostasis;2023-01-09

5. Registers, Their Place in Scientific Hierarchy and Clinical Significance on the Example of the RIETE Register;Flebologiia;2022